Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 51, 2021 - Issue 16
232
Views
3
CrossRef citations to date
0
Altmetric
Articles

An efficient synthesis and evaluation of some novel quinazolinone-pyrazole hybrids as potential antiproliferative agents

ORCID Icon & ORCID Icon
Pages 2498-2509 | Received 03 Apr 2021, Published online: 24 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Musherah M. Alshammari, Raoudha Soury, Khalaf M. Alenezi, Md. Mushtque, M. Moshahid Alam Rizvi & Ashanul Haque. (2022) Synthesis, characterization, anticancer and in silico studies of a pyrazole-tethered thiazolidine-2,4-dione derivative. Journal of Biomolecular Structure and Dynamics 40:23, pages 13075-13082.
Read now

Articles from other publishers (2)

Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah & Pradeep Kumar. (2022) Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals 15:9, pages 1071.
Crossref
Oya Unsal Tan & Merve Zengin. (2021) Insights into the chemistry and therapeutic potential of acrylonitrile derivatives. Archiv der Pharmazie 355:3, pages 2100383.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.